Metformin Therapy for Acne Vulgaris: A Meta-Analysis
Pharmaceuticals · 05.06.2024 · 17 (6) · 728
DOI: 10.3390/ph17060728 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Pharmaceuticals, online erschienen am 05.06.2024. Verfasst von Lidia Szefler und 5 weiteren Autor:innen. Beteiligte Einrichtung: Students' Scientific Society at Poznań University of Medical Sciences, Student's Scientific Section of Endocrinology, Department of Endocrinology, Me…. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 67 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Acne vulgaris is a common disease, which occurs in adolescents as well as adults and has a significant influence on the patient’s quality of life (QoL) in every aspect. Due to resistance to standard therapies, it has become necessary to prospect for new treatment strategies. It is important to highlight that the diagnosis and treatment of the underlying cause of acne such as metabolic and hormonal disorders may significantly improve the effectiveness of acne treatment. The correlation between Insulin Resistance (IR) and acne has been proven. Both disorders share many common occurrence factors and activation pathways. Metformin, an antihyperglycemic agent, seems to be a possible therapy option, not only because of its insulin sensitizing ability but also via plenty of additional effects of this medicine. While the efficiency of metformin therapy in patients with acne and Polycystic Ovary Syndrome (PCOS) is well explored, it is still necessary to evaluate it in patients without any endocrinopathies. This meta-analysis aimed to estimate the effectiveness of oral metformin as a monotherapy in acne patients without PCOS or other endocrinopathies. Study selection was performed with included criteria such as no PCOS and other endocrinopathies diagnosed, oral administration of metformin, and metformin in monotherapy. Selected studies contained comparisons in the Global Acne Grading System (GAGS) before and after metformin therapy. Statistical analysis detected significant improvement in skin condition after treatment with metformin.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Students' Scientific Society at Poznań University of Medical Sciences, Student's Scientific Section of Endocrinology, Department of Endocrinology, Metabolism and Internal Medicine, Poznań University of Medical Sciences,…
- Department of Allergic and Occupational Skin Diseases, Poznań University of Medical Sciences, 61-701 Poznan, Poland.
- Department of Dermatology and Venerology, Poznań University of Medical Sciences, 61-701 Poznan, Poland.
- Department of Computer Sciences and Statistics, Poznań University of Medical Sciences, 61-701 Poznan, Poland.
- Department of Endocrinology, Metabolism and Internal Medicine, Poznań University of Medical Science, 61-701 Poznan, Poland.
ORCID-Profile: Barbara Wieckowska
Zitieren
APA
Szefler, L., Szybiak-Skora, W., Sadowska-Przytocka, A., Zaba, R., Wieckowska, B., & Lacka, K. (2024). Metformin Therapy for Acne Vulgaris: A Meta-Analysis. Pharmaceuticals, 17(6), 728. https://doi.org/10.3390/ph17060728
Vancouver
Szefler L, Szybiak-Skora W, Sadowska-Przytocka A, Zaba R, Wieckowska B, Lacka K. Metformin Therapy for Acne Vulgaris: A Meta-Analysis. Pharmaceuticals. 2024;17(6):728. doi:10.3390/ph17060728
BibTeX
@article{Szefler2024,
author = {Szefler, Lidia and Szybiak-Skora, Weronika and Sadowska-Przytocka, Anna and Zaba, Ryszard and Wieckowska, Barbara and Lacka, Katarzyna},
title = {Metformin Therapy for Acne Vulgaris: A Meta-Analysis},
journal = {Pharmaceuticals},
year = {2024},
volume = {17},
number = {6},
pages = {728},
doi = {10.3390/ph17060728}
}
EUVIMED